NEW YORK (GenomeWeb News) – Abbott reported today that its molecular diagnostics sales grew 4 percent year over year for its fourth quarter ended Dec. 31, 2012.

The diagnostics, medical devices, and pharmaceuticals giant reported molecular diagnostics sales of $131 million for the quarter, up from $126 million for the fourth quarter of 2011. Its core laboratory diagnostics revenues for the quarter were also up 4 percent to $908 million, while its point-of-care diagnostics sales climbed 15 percent to $90 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.